Works matching AU Hisashi Yamanaka


Results: 294
    1
    2

    Continual Maintenance of Remission Defined by the ACR/EULAR Criteria in Daily Practice Leads to Better Functional Outcomes in Patients with Rheumatoid Arthritis.

    Published in:
    2017
    By:
    • Kumi Shidara;
    • Ayako Nakajima;
    • Eisuke Inoue;
    • Daisuke Hoshi;
    • Naoki Sugimoto;
    • Yohei Seto;
    • Eiichi Tanaka;
    • Shigeki Momohara;
    • Atsuo Taniguchi;
    • Hisashi Yamanaka;
    • Shidara, Kumi;
    • Nakajima, Ayako;
    • Inoue, Eisuke;
    • Hoshi, Daisuke;
    • Sugimoto, Naoki;
    • Seto, Yohei;
    • Tanaka, Eiichi;
    • Momohara, Shigeki;
    • Taniguchi, Atsuo;
    • Yamanaka, Hisashi
    Publication type:
    journal article
    3
    4
    5
    6

    IL-23 and Th17 Disease in Inflammatory Arthritis.

    Published in:
    Journal of Clinical Medicine, 2017, v. 6, n. 9, p. 81, doi. 10.3390/jcm6090081
    By:
    • Toru Yago;
    • Yuki Nanke;
    • Manabu Kawamoto;
    • Tsuyoshi Kobashigawa;
    • Hisashi Yamanaka;
    • Shigeru Kotake
    Publication type:
    Article
    7
    8

    Methotrexate, Tofacitinib, and Biologic Disease-Modifying Antirheumatic Drug Safety and Effectiveness Among Patients with Rheumatoid Arthritis in Japan: CorEvitas Registry Observational Study.

    Published in:
    Rheumatology & Therapy, 2024, v. 11, n. 5, p. 1237, doi. 10.1007/s40744-024-00700-2
    By:
    • Tanaka, Yoshiya;
    • Kishimoto, Mitsumasa;
    • Sonomoto, Koshiro;
    • Amano, Koichi;
    • Harigai, Masayoshi;
    • Onofrei, Alina;
    • O'Brien, Jacqueline;
    • Margolin, Zachary;
    • Barr, Christine;
    • Mizuno, Yasushi;
    • Agarwal, Ekta;
    • Sugiyama, Naonobu;
    • Yamanaka, Hisashi
    Publication type:
    Article
    9
    10

    Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases.

    Published in:
    Rheumatology & Therapy, 2023, v. 10, n. 1, p. 201, doi. 10.1007/s40744-022-00505-1
    By:
    • Salinas, Claudia A.;
    • Louder, Anthony;
    • Polinski, Jennifer;
    • Zhang, Tancy C.;
    • Bower, Hannah;
    • Phillips, Syd;
    • Song, Yufei;
    • Rashidi, Emaan;
    • Bosan, Rafia;
    • Chang, Hsiu-Ching;
    • Foster, Nicole;
    • Gershenson, Bernice;
    • Yamanaka, Hisashi;
    • Kishimoto, Mitsumasa;
    • Tanaka, Yoshiya;
    • Fischer, Peter;
    • Zhu, Baojin;
    • Faries, Douglas;
    • Mai, Xiaodan;
    • Doherty, Brett T.
    Publication type:
    Article
    11
    12
    13
    14

    Lower injection‐site reactions and long‐term safety, immunogenicity, and efficacy of etanercept biosimilar YLB113: Results from a post‐hoc analysis of a double‐blind, randomized, phase III comparative study and its open‐label extension in patients with rheumatoid arthritis

    Published in:
    International Journal of Rheumatic Diseases, 2023, v. 26, n. 1, p. 108, doi. 10.1111/1756-185X.14462
    By:
    • Yamanaka, Hisashi;
    • Tanaka, Yoshiya;
    • Hibino, Toshihiko;
    • Unmesh, Gopalakrishnan;
    • Shah, Chirag;
    • Bakhle, Dhananjay;
    • Stefanidis, Dimitris
    Publication type:
    Article
    15
    16
    17
    18

    No increased risk of herpes zoster in TNF inhibitor and non‐TNF inhibitor users with rheumatoid arthritis: epidemiological study using the Japanese health insurance database.

    Published in:
    International Journal of Rheumatic Diseases, 2018, v. 21, n. 9, p. 1670, doi. 10.1111/1756-185X.13300
    By:
    • Sakai, Ryoko;
    • Kasai, Shoko;
    • Hirano, Fumio;
    • Harada, Sayoko;
    • Kihara, Mari;
    • Yokoyama, Waka;
    • Tsutsumino, Michi;
    • Nagasaka, Kenji;
    • Koike, Ryuji;
    • Yamanaka, Hisashi;
    • Miyasaka, Nobuyuki;
    • Harigai, Masayoshi
    Publication type:
    Article
    19
    20

    A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility.

    Published in:
    Nature Genetics, 2010, v. 42, n. 6, p. 515, doi. 10.1038/ng.583
    By:
    • Kochi, Yuta;
    • Okada, Yukinori;
    • Suzuki, Akari;
    • Ikari, Katsunori;
    • Terao, Chikashi;
    • Takahashi, Atsushi;
    • Yamazaki, Keiko;
    • Hosono, Naoya;
    • Myouzen, Keiko;
    • Tsunoda, Tatsuhiko;
    • Kamatani, Naoyuki;
    • Furuichi, Tatsuya;
    • Ikegawa, Shiro;
    • Ohmura, Koichiro;
    • Mimori, Tsuneyo;
    • Matsuda, Fumihiko;
    • Iwamoto, Takuji;
    • Momohara, Shigeki;
    • Yamanaka, Hisashi;
    • Yamada, Ryo
    Publication type:
    Article
    21
    22
    23

    Factors contributing to the improvement in Japanese Health Assessment Questionnaire after 3 years of treatment with abatacept in biologic-naïve rheumatoid arthritis patients: Interim results of a long-term, observational, multicentre study in Japan (ORIGAMI)

    Published in:
    Modern Rheumatology, 2025, v. 35, n. 1, p. 17, doi. 10.1093/mr/roae043
    By:
    • Kenta Misaki;
    • Eiichi Tanaka;
    • Eisuke Inoue;
    • Naoto Tamura;
    • Fuminori Hirano;
    • Yoshinori Taniguchi;
    • Hiroshi Sato;
    • Taio Naniwa;
    • Hideto Oshikawa;
    • Tamami Yoshitama;
    • Yuya Takakubo;
    • Yoko Suzuki;
    • Shinkichi Himeno;
    • Katsuki Tsuritani;
    • Shigeru Matsumoto;
    • Hisashi Yamanaka;
    • Masayoshi Harigai
    Publication type:
    Article
    24
    25

    Evaluation of the Rheumatoid Arthritis Observation of Biologic Therapy risk score in Japanese patients with rheumatoid arthritis starting first biologic disease–modifying antirheumatic drugs: A validation study using the Institute of Rheumatology, Rheumatoid Arthritis cohort data

    Published in:
    Modern Rheumatology, 2024, v. 34, n. 4, p. 693, doi. 10.1093/mr/road066
    By:
    • Tomoaki Higuchi;
    • Eiichi Tanaka;
    • Eisuke Inoue;
    • Mai Abe;
    • Kumiko Saka;
    • Eri Sugano;
    • Naohiro Sugitani;
    • Yoko Higuchi;
    • Moeko Ochiai;
    • Rei Yamaguchi;
    • Katsunori Ikari;
    • Hisashi Yamanaka;
    • Masayoshi Harigai
    Publication type:
    Article
    26

    Contribution of the factors to EuroQol 5 Dimensions in rheumatoid arthritis patients achieving low disease activity/remission with abatacept treatment: Post hoc subgroup analyses of the Japanese real-world observational 'ORIGAMI' study.

    Published in:
    Modern Rheumatology, 2024, v. 34, n. 4, p. 686, doi. 10.1093/mr/road082
    By:
    • Masayoshi Harigai;
    • Eiichi Tanaka;
    • Eisuke Inoue;
    • Naoto Tamura;
    • Kenta Misaki;
    • Takanori Azuma;
    • Shintaro Hirata;
    • Fuminori Hirano;
    • Yoshinori Taniguchi;
    • Masaki Mitsuhashi;
    • Masahiro Kondo;
    • Motohiro Oribe;
    • Kazutoshi Aoki;
    • Michiaki Kadode;
    • Tsuritani Katsuki;
    • Hisashi Yamanaka
    Publication type:
    Article
    27
    28

    Long-term evaluation of E6011, an anti-fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to biological disease-modifying antirheumatic drugs.

    Published in:
    Modern Rheumatology, 2024, v. 34, n. 1, p. 45, doi. 10.1093/mr/road005
    By:
    • Tanaka, Yoshiya;
    • Takeuchi, Tsutomu;
    • Yamanaka, Hisashi;
    • Nanki, Toshihiro;
    • Umehara, Hisanori;
    • Yasuda, Nobuyuki;
    • Tago, Fumitoshi;
    • Kitahara, Yasumi;
    • Kawakubo, Makoto;
    • Torii, Kentaro;
    • Hojo, Seiichiro;
    • Kawano, Tetsu;
    • Imai, Toshio
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35

    Non-drug and surgical treatment algorithm and recommendations for the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis—secondary publication.

    Published in:
    Modern Rheumatology, 2023, v. 33, n. 1, p. 36, doi. 10.1093/mr/roac019
    By:
    • Hiromu Ito;
    • Keiichiro Nishida;
    • Toshihisa Kojima;
    • Isao Matsushita;
    • Masayo Kojima;
    • Shintaro Hirata;
    • Yuko Kaneko;
    • Mitsumasa Kishimoto;
    • Masataka Kohno;
    • Masaaki Mori;
    • Akio Morinobu;
    • Atsuko Murashima;
    • Yohei Seto;
    • Takahiko Sugihara;
    • Eiichi Tanaka;
    • Takeo Nakayama;
    • Hisashi Yamanaka;
    • Yutaka Kawahito;
    • Masayoshi Harigai
    Publication type:
    Article
    36

    Drug treatment algorithm and recommendations from the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis—secondary publication.

    Published in:
    Modern Rheumatology, 2023, v. 33, n. 1, p. 21, doi. 10.1093/mr/roac017
    By:
    • Yutaka Kawahito;
    • Akio Morinobu;
    • Yuko Kaneko;
    • Masataka Kohno;
    • Shintaro Hirata;
    • Mitsumasa Kishimoto;
    • Yohei Seto;
    • Takahiko Sugihara;
    • Eiichi Tanaka;
    • Hiromu Ito;
    • Toshihisa Kojima;
    • Isao Matsushita;
    • Keiichiro Nishida;
    • Masaaki Mori;
    • Atsuko Murashima;
    • Hisashi Yamanaka;
    • Takeo Nakayama;
    • Masayo Kojima;
    • Masayoshi Harigai
    Publication type:
    Article
    37
    38
    39
    40

    Differences in patients' population and efficacy/effectiveness of biologic disease-modifying antirheumatic drugs between randomized controlled trials and real-world settings in patients with rheumatoid arthritis - using the IORRA cohort.

    Published in:
    Modern Rheumatology, 2022, v. 32, n. 4, p. 675, doi. 10.1093/mr/roab067
    By:
    • Eri Sugano;
    • Eiichi Tanaka;
    • Eisuke Inoue;
    • Ryoko Sakai;
    • Mai Abe;
    • Kumiko Saka;
    • Naohiro Sugitani;
    • Moeko Ochiai;
    • Rei Yamaguchi;
    • Yoko Higuchi;
    • Naoki Sugimoto;
    • Katsunori Ikari;
    • Ayako Nakajima;
    • Hisashi Yamanaka;
    • Masayoshi Harigai
    Publication type:
    Article
    41
    42

    Systematic review for the treatment of older rheumatoid arthritis patients informing the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis.

    Published in:
    Modern Rheumatology, 2022, v. 32, n. 2, p. 313, doi. 10.1080/14397595.2021.1912922
    By:
    • Takahiko Sugihara;
    • Yutaka Kawahito;
    • Akio Morinobu;
    • Yuko Kaneko;
    • Yohei Seto;
    • Toshihisa Kojima;
    • Hiromu Ito;
    • Masataka Kohno;
    • Takeo Nakayama;
    • Yasumori Sobue;
    • Keiichiro Nishida;
    • Isao Matsushita;
    • Atsuko Murashima;
    • Masaaki Mori;
    • Eiichi Tanaka;
    • Shintaro Hirata;
    • Mitsumasa Kishimoto;
    • Hisashi Yamanaka;
    • Masayo Kojima;
    • Masayoshi Harigai
    Publication type:
    Article
    43

    Systematic review and meta-analysis of biosimilar for the treatment of rheumatoid arthritis informing the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis.

    Published in:
    Modern Rheumatology, 2022, v. 32, n. 1, p. 74, doi. 10.1080/14397595.2021.1899591
    By:
    • Eiichi Tanaka;
    • Yutaka Kawahito;
    • Masataka Kohno;
    • Shintaro Hirata;
    • Mitsumasa Kishimoto;
    • Yuko Kaneko;
    • Hiroya Tamai;
    • Yohei Seto;
    • Akio Morinobu;
    • Takahiko Sugihara;
    • Atsuko Murashima;
    • Masayo Kojima;
    • Masaaki Mori;
    • Hiromu Ito;
    • Toshihisa Kojima;
    • Yasumori Sobue;
    • Keiichiro Nishida;
    • Isao Matsushita;
    • Takeo Nakayama;
    • Hisashi Yamanaka
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50

    Efficacy and safety of tacrolimus in patients with rheumatoid arthritis -- A systematic review and meta-analysis.

    Published in:
    Modern Rheumatology, 2021, v. 31, n. 1, p. 61, doi. 10.1080/14397595.2020.1719607
    By:
    • Yuko Kaneko;
    • Yutaka Kawahito;
    • Masayo Kojima;
    • Takeo Nakayama;
    • Shintaro Hirata;
    • Mitsumasa Kishimoto;
    • Hirahito Endo;
    • Yohei Seto;
    • Hiromu Ito;
    • Keiichiro Nishida;
    • Isao Matsushita;
    • Toshihisa Kojima;
    • Naoyuki Kamatani;
    • Kiichiro Tsutani;
    • Ataru Igarashi;
    • Mieko Hasegawa;
    • Nobuyuki Miyasaka;
    • Hisashi Yamanaka
    Publication type:
    Article